Masahiko Igarashi
Department of Laboratory Medicine
Yamagata University School of Medicine
Yamagata
Japan
[email]@med.id.yamagata-u.ac.jp
Name/email consistency: high
- Pioglitazone reduces atherogenic outcomes in type 2 diabetic patients. Igarashi, M., Hirata, A., Yamaguchi, H., Jimbu, Y., Tominaga, M. J. Atheroscler. Thromb. (2008)
- Effect of pioglitazone on atherogenic outcomes in type 2 diabetic patients: a comparison of responders and non-responders. Igarashi, M., Jimbu, Y., Kimura, M., Hirata, A., Yamaguchi, H., Tominaga, M. Diabetes Res. Clin. Pract. (2007)
- Characterization of activation of MAP kinase superfamily in vasculature from diabetic rats. Igarashi, M., Hirata, A., Yamaguchi, H., Sugae, N., Kadomoto-Antsuki, Y., Nozaki, H., Jimbu, Y., Tominaga, M. J. Atheroscler. Thromb. (2007)
- Role of angiotensin II type-1 and type-2 receptors on vascular smooth muscle cell growth and glucose metabolism in diabetic rats. Igarashi, M., Hirata, A., Nozaki, H., Kadomoto-Antsuki, Y., Tominaga, M. Diabetes Res. Clin. Pract. (2007)
- Mechanism of an inhibitory effect of nipradilol on rat vascular smooth muscle cell growth. Igarashi, M., Hirata, A., Yamaguchi, H., Sugae, N., Kadomoto, Y., Jimbu, Y., Daimon, M., Kato, T., Tominaga, M. J. Atheroscler. Thromb. (2003)
- Clinical utility and approach to estimate postprandial hypertriglycemia by a newly designed oral fat-loading test. Igarashi, M., Hirata, A., Yamauchi, T., Yamaguchi, H., Tsuchiya, H., Ohnuma, H., Jimbu, Y., Okuyama, Y., Shirata, T., Otsu, N., Fukuyama, H., Takahashi, S., Tominaga, M., Kato, T. J. Atheroscler. Thromb. (2003)
- Mechanisms of inhibitory effects of cerivastatin on rat vascular smooth muscle cell growth. Igarashi, M., Yamaguchi, H., Hirata, A., Tsuchiya, H., Ohnuma, H., Tominaga, M., Daimon, M., Kato, T. J. Cardiovasc. Pharmacol. (2002)
- Candesartan inhibits carotid intimal thickening and ameliorates insulin resistance in balloon-injured diabetic rats. Igarashi, M., Hirata, A., Yamaguchi, H., Tsuchiya, H., Ohnuma, H., Tominaga, M., Daimon, M., Kato, T. Hypertension (2001)
- Insulin activates p38 mitogen-activated protein (MAP) kinase via a MAP kinase kinase (MKK) 3/MKK 6 pathway in vascular smooth muscle cells. Igarashi, M., Yamaguchi, H., Hirata, A., Daimon, M., Tominaga, M., Kato, T. Eur. J. Clin. Invest. (2000)